ABL Diagnostics Société anonyme (EPA:ABLD)
France · Delayed Price · Currency is EUR 2.840
+0.040 (1.43%)
Apr 2, 2026, 4:12 PM CET
EPA:ABLD Market Cap
EPA:ABLD has a market cap or net worth of €45.76 million as of April 2, 2026. Its market cap has decreased by -43.76% in one year.
Market Cap
45.76M
Enterprise Value
47.53M
Revenue
6.23M
Ranking
n/a
PE Ratio
98.76
Stock Price
€2.84
Market Cap Chart
Since November 17, 2000, EPA:ABLD's market cap has increased from 2.51M to 45.76M, an increase of 1,724.63%. That is a compound annual growth rate of 12.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 45.76M | -5.33% |
| Dec 31, 2025 | 48.34M | 21.95% |
| Dec 31, 2024 | 39.64M | -74.64% |
| Dec 29, 2023 | 156.30M | 3,819.50% |
| Dec 30, 2021 | 3.99M | 34.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 100.07B |
| EssilorLuxottica Société anonyme | 88.27B |
| Sartorius Stedim Biotech | 16.32B |
| Ipsen | 13.75B |
| Valerio Therapeutics Société anonyme | 59.15M |
| Klea Holding | 55.93M |
| Fermentalg | 48.17M |
| THX Pharma Société Anonyme | 42.08M |